2022 AASLD Meeting Review
This update will be presented by members of the hepatology team from the Division of Gastroenterology and Hepatology at the Medical College of Wisconsin. This review will include diverse topics such as Viral Hepatitis, Alcoholic Liver Disease, NAFLD Metabolic Liver Disease, and Liver Transplant. There will be plenty of time for questions and answers.
Target Audience
Gastroenterologists, Hepatologists, Nurse Practitioners, and Physician Assistants
Learning Objectives
Participants who engage in this educational interventation will be able to:
- Recognize the clinical presentation of biliary disease and how to initiate an evaluation.
- Identify the risk factors for development of hepatocellular carcinoma (HCC) and how to initiate a screening and surveillance protocol.
- Identify patients at risk for the development of non-alcoholic fatty liver disease and how to initiate an evaluation.
AASLD 2022 Meeting Review
February 18, 2023
Course Director: José Franco, MD
7:30-8:00 Registration and continental breakfast
8:00-8:10 Welcome
José Franco, MD
8:10-8:40 Viral Hepatitis
Kia Saeian, MD
8:40-9:10 NAFLD
Achuthan Souria, MD
9:10-9:25 BREAK
9:25-9:55 Metabolic Liver Disease
Juan Trivella, MD
9:55-10:25 Transplant
Francisco Durazo, MD
10:25-10:40 BREAK
10:40-11:10 Alcoholic Liver Disease
Veronica Loy, DO
11:10-11:40 Miscellaneous
Kia Saeian, MD; Francisco Durazo, MD; Achuthan Souria, MD; Juan Trivella, MD,
Veronica Loy, DO
11:40-12:00 Summary and Wrap-Up
12:00 LUNCH
Medical College of Wisconsin
M1060-Alumni Center
8701 Watertown Plank Road
Milwaukee, WI 53226
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Jose Franco, MD
Achuthan Souria, MD
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Kia Saeian, MD: Abbvie and Calliditas Therapeutics AB for the research support for a hepatitis C treatment protocol
Available Credit
- 3.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.25 Hours of ParticipationHours of Participation credit.
Abbvie Pharmaceuticals
Salix Pharmaceuticals
Gilead Pharmaceuticals
Price
For a more user-friendly registration and payment experience, Google Chrome and Mozilla Firefox are the recommended browsers.
Registration scams:
Registration for courses managed by MCW Office of Continuing Professional Development can only be completed through our portal at https://ocpe.mcw.edu/. Course registrations made through other sites cannot be honored. MCW Office of Continuing Professional Development is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.
Please report any unauthorized websites or solicitations for registrations to cme@mcw